Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9015874 | Pharmacology & Therapeutics | 2005 | 17 Pages |
Abstract
During the past decade, an emerging body of evidence has accumulated that cardiac transcription factors control a cardiac gene program and play a critical role in transcriptional regulation during cardiogenesis and during the adaptive process in adult hearts. Especially, an evolutionally conserved homeobox transcription factor Csx/Nkx2-5 has been in the forefront in the field of cardiac biology, providing molecular insights into the mechanisms of cardiac development and diseases. Csx/Nkx2-5 is indispensable for normal cardiac development, and mutations of the gene are associated with human congenital heart diseases (CHD). In the present review, the regulation of a cardiac gene program by Csx/Nkx2-5 is summarized, with an emphasis on its role in the cardiac development and diseases.
Keywords
nESMLC2vTGF-βcardiac ankyrin repeat proteinIRX4PI3-kinaseSca-1TAK1homeoboxVSDCHDCKIIBNPSRFTOFANPFGFDORVDPPMEF2DMSOStem Cell Antigen-1double-outlet right ventricleWinglessCongenital heart diseaseCongenital heart diseasestransforming growth factor-βDecapentaplegicTranscriptional regulationCardiac developmentCardioprotectionAtrioventricularDimethyl sulfoxideMyosin heavy chainnuclear export signalmyocyte enhancer factor 2fibroblast growth factorserum response factorPhosphatidylinositol 3-kinaseMHCBMPVentricular septal defectatrial septal defectASDHopCardiac hypertrophybone morphogenic proteinbrain natriuretic peptideatrial natriuretic peptidecasein kinase IICarp
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Hiroshi Akazawa, Issei Komuro,